Franklin Resources’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $1.44M | Buy |
|
|||||
|
2023
Q1 | $264K | Buy |
|
|||||
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $7.41M | Sell |
|
|||||
|
2022
Q2 | $19.3M | Sell |
|
|||||
|
2022
Q1 | $27.9M | Sell |
|
|||||
|
2021
Q4 | $22.5M | Sell |
|
|||||
|
2021
Q3 | $103M | Sell |
|
|||||
|
2021
Q2 | $196M | Sell |
|
|||||
|
2021
Q1 | $146M | Sell |
|
|||||
|
2020
Q4 | $181M | Buy |
|
|||||
|
2020
Q3 | $136M | Buy |
|
|||||
|
2020
Q2 | $213M | Buy |
|
|||||
|
2020
Q1 | $174M | Sell |
|
|||||
|
2019
Q4 | $254M | Sell |
|
|||||
|
2019
Q3 | $101M | Buy |
|
|||||
|
2019
Q2 | $109M | Buy |
|
|||||
|
2019
Q1 | $83.7M | Buy |
|
|||||
|
2018
Q4 | $53.9M | Buy |
|
|||||
|
2018
Q3 | $70.2M | Buy |
|
|||||
|
2018
Q2 | $9.28M | Buy |
|
|||||
|
2018
Q1 | $5.44M | Hold |
|
|||||
|
2017
Q4 | $7.52M | Buy |
|
|||||
|
2017
Q3 | $7.78M | Buy |
|